IPO
IPO filing, visualized

Neucleus Group Ltd

NasdaqMalaysiaF-1/A · Jul 15, 2026Filed

No price range yet · latest SEC filing Jul 15, 2026.

Pinch-zoom for details.

The offering

Price range
$4–$5
per share
Shares offered
4.50M
sold by the company
Raise at $4.5 midpoint
$20.2M
4,500,000 × $4.5, before fees

What the company does

Malaysian parenting-consultation business using DNA testing, under the Neucleus Education brand; started in 2022.

Revenue

Fiscal year

Net result

Fiscal year

Who controls the votes

Insiders' voting power
50%

Share of voting power held by the founders or controlling holders after the offering, as stated in the filing.

Things to weigh

  • Insiders keep control: about 50% of the voting power after the offering.

The numbers

MYRFY2024FY2025YoY
Revenue274K3.10M+1,030%
Net result53.5K938K+1,652%

Values as filed, shortened (K = thousand, M = million, B = billion); losses in parentheses. Change columns compare each period with the same period a year earlier; a bigger loss shows as a negative change. Green is better for the company, red worse; n/m where the sign flips.

Risks

  1. We have produced limited revenue
  2. We are dependent on our Directors and business unit heads for continued success and growth of our business
  3. We may fail to maintain and grow our customer base or keep our customers engaged through our services
  4. We may not accurately predict the adoption of our scientific parental consultation services, or any resulting impact on our revenues…

The filing's own risk-factor headings, shortened.

Strategy

The filing doesn't set out its strategy in a list we could read.

Source: Neucleus Group Ltd's Form F-1/A, filed with the SEC on Jul 15, 2026 (preliminary prospectus). Figures are as filed; changes are worked out from them. Not investment advice.

10KDecoder10KDecoder.com

10KDecoder (10-K Decoder): decode SEC 10-K filings and IPO prospectuses into dashboards and infographics.